Across TCGA pan-cancer cohorts, EXOGP1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of EXOGP1’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where EXOGP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EXOGP1 is over-expressed in tumor.
THCA and BRCA are the cancer types where EXOGP1 tumor–normal differential expression is most reproducible.